HeyVoli is evolving from a generative AI platform into an AI infrastructure company building the foundation for connected healthcare.
“HeyVoli is entering a new chapter.”
What began as a generative AI platform is now evolving toward a much larger ambition: building intelligent infrastructure for healthcare systems. The transition marks a fundamental shift in the company’s direction, from delivering individual AI capabilities to building the underlying systems that can connect healthcare data, workflows, operations, and intelligence. HeyVoli believes the next major transformation in healthcare will not come from another standalone application.
It will come from making the entire healthcare system more connected, intelligent, and capable of acting as one.
Healthcare Doesn't Need More Silos
Healthcare has adopted technology at an extraordinary pace.
Hospitals operate electronic health records. Laboratories run sophisticated diagnostic systems. Pharmacies manage complex fulfillment networks. Insurers operate claims infrastructure. Providers use specialized clinical applications. Patients interact through increasingly digital channels.
Yet much of this technology still operates in isolation. Data remains fragmented. Workflows cross organizational boundaries without a common operating layer. Critical signals are generated but not always connected to the decisions they should inform. The challenge is no longer simply digitization. The challenge is coordination.
WHO has increasingly emphasized that interoperable systems, trusted data, governance, and digital infrastructure are foundational to deploying AI safely and effectively at scale. HeyVoli is building around this fundamental problem.
Building the Infrastructure Behind Connected Healthcare
The company’s new direction is centered on a healthcare infrastructure architecture designed to connect the many layers of a healthcare organization and its surrounding ecosystem.
Rather than replacing existing systems, HeyVoli’s approach is designed to work across them.
Its architecture brings together areas including patient experience, clinical systems, care delivery, operational workflows, supply chain, financial and insurance systems, data and intelligence, interoperability, ecosystem coordination, and underlying infrastructure.
At the foundation is CoreK, HeyVoli’s intelligent systems layer designed to connect data, events, workflows, intelligence, security, and governance across the broader healthcare environment. Above this foundation, the platform is being developed around specialized infrastructure capabilities including CareOS, FlowGrid, SignalNet, and TwinMind.
Together, these components represent a shift from building individual AI features to building the infrastructure through which healthcare intelligence can operate.
Intelligence That Works Across the System
The next generation of healthcare AI will require more than powerful models.
AI systems need access to the right information, within the right context, at the right time. They also need appropriate permissions, interoperability, observability, governance, and the ability to interact with existing workflows. Recent healthcare technology research increasingly points toward modular, interoperable architectures rather than isolated AI point solutions.
HeyVoli’s architecture is designed around this principle. Instead of asking healthcare organizations to adopt another standalone application, the company is building toward infrastructure that can sit across existing environments and help coordinate how information and intelligence move through them.
This includes supporting interoperability, workflow orchestration, real-time signals, operational intelligence, and AI-enabled decision support.
Designed for the Healthcare Ecosystem
HeyVoli’s vision extends beyond hospitals and individual providers.
The infrastructure is being designed for a broader healthcare ecosystem involving patients, providers, hospitals, laboratories, pharmacies, payers, technology companies, public health organizations, and other ecosystem participants.
The goal is to create a more connected environment where systems can communicate, workflows can coordinate, and intelligence can move across organizational boundaries without requiring every participant to operate on the same application.
This direction aligns with the broader movement toward open and interoperable digital health infrastructure. In India, initiatives such as the Unified Health Interface and other digital health infrastructure programs are similarly focused on enabling healthcare participants to connect across platforms.
A New Chapter for HeyVoli
The transition represents more than a change in product positioning. It marks a fundamental change in what HeyVoli intends to build.
- From generating content to enabling intelligence.
- From individual AI tools to connected systems.
- From point solutions to healthcare infrastructure.
The company’s long-term ambition is to create an intelligent infrastructure layer that helps healthcare organizations move from fragmented technology environments toward systems that are more connected, coordinated, observable, and capable of continuous improvement.
As healthcare AI moves from experimentation toward production environments, infrastructure, interoperability, security, and governance are becoming increasingly important to sustainable adoption. HeyVoli believes the next phase of healthcare transformation will not be defined by a single AI model or application.
It will be defined by how intelligently the entire system can work together.
HeyVoli is building for that system.
A New Chapter for HeyVoli
“They are an essential part of daily indulgence for high-net-worth individuals, a cherished component of celebrations for many consumers, and a valuable investment for collectors. Whether enjoyed regularly, during special occasions, or as part of a curated collection, fine wines embody prestige, passion, joy, conviviality, and a deep appreciation for quality.”
said Rebeca Lopes, a partner at Execor and leader of the firm’s global Fashion & Luxury practice, who is also the lead author of the study.